Hospitals can pose potential risks to patients and staff through the threat of infections caused by pathogens such as MRSA, E. coli and C. difficile (C. diff.).

To combat the rise of C. diff infections at hospital facilities, 3M recently launched 3M C. diff Solution Tablets, providing a proven, effective alternative to bleach and peracetic acid disinfectants. Now available for use in the U.S., the new product delivers on effectiveness, efficiency and value.

“We are excited to provide our customers with an effective solution for the battle against C. diff,” said Adrian Cook, product marketer for chemicals at 3M Commercial Solutions Division. “The reduction and prevention of infections is an important focus for our customers and we look forward to continuing our work in ensuring safe environments.”

In addition to the new product launch, 3M Commercial Solutions Division also announced the expansion of its Flow Control System product line through the introduction of four additional chemical offerings including: 3M Quat Disinfectant Cleaner Concentrate 5A; 3M Neutral Quat Disinfectant Cleaner Concentrate 23A; Scotchgard Pretreatment Cleaner Concentrate 28A; and 3M Bathroom Cleaner Concentrate 44A.